BOSTON - On Thursday, September 30, 2004, surgeons from Dana-Farber/Brigham and Women's Cancer Center hosted a live Webcast in which participants can view and learn more about new, less invasive surgical techniques to address early (nonmetastatic) prostate cancer. During this Webcast, surgeons performed a bilateral nerve sparing radical prostatectomy and demonstrated specific techniques designed to reduce side effects of surgery including incontinence and sexual dysfunction. Medical professionals from other hospitals and medical schools, those interested in CME credits and the general public, are invited to log-on to see the archive of the Webcast by visiting www.brighamandwomens.org/surgerywebcast.
Michael O'Leary, MD, an accomplished urologist in BWH's division of Urologic Surgery and Dana-Farber/Brigham and Women's Cancer Center and associate professor of surgery at Harvard Medical School (HMS) narrated the procedure. Jerome P. Richie, MD, chief of the Division and professor of surgery at HMS demonstrated the surgical techniques with assistance from Gregory S. Adey, MD a resident in the HMS program in Urology.
First Seen Webcast: September 30 at 4:30 p.m. EDT (20:30 UTC)
According to O'Leary, "Many of our patients are younger men who have long, healthy lives to look forward to, which is why radical prostatectomy is often a recommended treatment option in that it offers high recovery rates. However, because we want to preserve quality of life for our patients, nerve-sparing techniques have been developed and refined so that we have come to the point where continence and sexual function return after a period of time."
In addition, Richie commented, "Demonstrating this procedure via Webcast will provide our viewers with insight into this disease, screening and diagnosis and the new surgical techniques that will ultimately help physicians and their patients make more informed decisions about their treatment options."
The bilateral nerve sparing radical prostatectomy procedure requires smaller incisions than a traditional radical prostatectomy and poses the risk of fewer complications. During this procedure, surgeons removed the prostate gland and any surrounding tissue that is at risk for cancer.
Prostate cancer is the most common cancer in America. It is estimated that there are more than two million American men currently living with this disease. In 2004, more than 230,000 men will be diagnosed with prostate cancer, with nearly 30,000 men dying from this disease. Detected early and treated, long-term survival rates continue to rise year after year.
The September 30, 2004 event is the third in a series of four live Webcasts scheduled for 2004 and the seventh BWH has performed to date. For this procedure, camera crews staffed the operating theater with complete access to the surgery. Viewers were able to see 3D images of the procedure during the Webcast.
To learn more about this and previous Brigham and Women's Hospital Webcasts, visit www.brighamandwomens.org/surgerywebcast.
Dana-Farber/Brigham and Women's Cancer Center is a program of Dana-Farber/Partners CancerCare, a collaboration in adult oncology among three world leaders in cancer diagnosis and treatment - Dana-Farber Cancer Institute, Brigham and Women's Hospital and Massachusetts General Hospital. Through this adult oncology collaboration, the world's leading specialists coordinate research, training and all aspects of patient care to fight cancer.